Jan 23,2015 11:37 AM
The stock has hit a high of Rs. 38.90 and a low of Rs. 34.50.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||476.05||35.58||114,220.34||1,155.85||0.84||2,750.41||101.68|
|Dr Reddys Laboratories Ltd||3,961.20||22.41||65,824.09||502.80||0.63||2,837.90||914.23|
|Divis Laboratories Ltd||2,382.25||49.79||63,241.25||360.73||0.67||1,390.49||266.77|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Beryl Drugs Ltd is engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. The company also provides a range of eye/ear drops, veterinary products, and injections. It sells its products through its sales and distribution network. In addition, the company offers research and development, as well as ... More
Reports by beryl-drugs-ltd
12 Feb 2020
04 Feb 2020
BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is schedu... More
12 Nov 2019
06 Nov 2019
Quarterly ResultsOUTCOME OF 26TH BOARD MEETING OF THE COMPANY(As Per BSE Announcement Dated 12.11.20... More